Photosensitizing Agents

"Photosensitizing Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Drugs that are pharmacologically inactive but when exposed to ultraviolet radiation or sunlight are converted to their active metabolite to produce a beneficial reaction affecting the diseased tissue. These compounds can be administered topically or systemically and have been used therapeutically to treat psoriasis and various types of neoplasms.

Descriptor ID	D017319
MeSH Number(s)	D27.505.954.444.600 D27.505.954.600.710
Concept/Terms	Photosensitizing Agents Photosensitizing Agents Agents, Photosensitizing Photosensitizers Photosensitizing Effect Photosensitizing Effect Effect, Photosensitizing Photosensitizing Effects Effects, Photosensitizing

Below are MeSH descriptors whose meaning is more general than "Photosensitizing Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Dermatologic Agents [D27.505.954.444]
Photosensitizing Agents [D27.505.954.444.600]
Radiation-Sensitizing Agents [D27.505.954.600]
Photosensitizing Agents [D27.505.954.600.710]

Below are MeSH descriptors whose meaning is related to "Photosensitizing Agents".

Below are MeSH descriptors whose meaning is more specific than "Photosensitizing Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Photosensitizing Agents" by people in this website by year, and whether "Photosensitizing Agents" was a major or minor topic of these publications.

Bar chart showing 9 publications over 8 distinct years, with a maximum of 2 publications in 2021

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	1	0	1
2010	0	1	1
2011	0	1	1
2016	0	1	1
2017	1	0	1
2018	1	0	1
2020	0	1	1
2021	1	1	2

Below are the most recent publications written about "Photosensitizing Agents" by people in Profiles.

Li X, Xiao H, Xiu W, Yang K, Zhang Y, Yuwen L, Yang D, Weng L, Wang L. Mitochondria-Targeting MoS2-Based Nanoagents for Enhanced NIR-II Photothermal-Chemodynamic Synergistic Oncotherapy. ACS Appl Mater Interfaces. 2021 Dec 01; 13(47):55928-55938.

View in: PubMed
Yuwen L, Qiu Q, Xiu W, Yang K, Li Y, Xiao H, Yang W, Yang D, Wang L. Hyaluronidase-responsive phototheranostic nanoagents for fluorescence imaging and photothermal/photodynamic therapy of methicillin-resistant Staphylococcus aureus infections. Biomater Sci. 2021 Jun 15; 9(12):4484-4495.

View in: PubMed
Ji Y, Jones C, Baek Y, Park GK, Kashiwagi S, Choi HS. Near-infrared fluorescence imaging in immunotherapy. Adv Drug Deliv Rev. 2020 12; 167:121-134.

View in: PubMed
Jadia R, Kydd J, Rai P. Remotely Phototriggered, Transferrin-Targeted Polymeric Nanoparticles for the Treatment of Breast Cancer. Photochem Photobiol. 2018 07; 94(4):765-774.

View in: PubMed
Huang L, Li Z, Zhao Y, Yang J, Yang Y, Pendharkar AI, Zhang Y, Kelmar S, Chen L, Wu W, Zhao J, Han G. Enhancing Photodynamic Therapy through Resonance Energy Transfer Constructed Near-Infrared Photosensitized Nanoparticles. Adv Mater. 2017 07; 29(28).

View in: PubMed
Huang L, Li Z, Zhao Y, Zhang Y, Wu S, Zhao J, Han G. Ultralow-Power Near Infrared Lamp Light Operable Targeted Organic Nanoparticle Photodynamic Therapy. J Am Chem Soc. 2016 11 09; 138(44):14586-14591.

View in: PubMed
Valdés PA, Moses ZB, Kim A, Belden CJ, Wilson BC, Paulsen KD, Roberts DW, Harris BT. Gadolinium- and 5-aminolevulinic acid-induced protoporphyrin IX levels in human gliomas: an ex vivo quantitative study to correlate protoporphyrin IX levels and blood-brain barrier breakdown. J Neuropathol Exp Neurol. 2012 Sep; 71(9):806-13.

View in: PubMed
Valdés PA, Kim A, Brantsch M, Niu C, Moses ZB, Tosteson TD, Wilson BC, Paulsen KD, Roberts DW, Harris BT. ?-aminolevulinic acid-induced protoporphyrin IX concentration correlates with histopathologic markers of malignancy in human gliomas: the need for quantitative fluorescence-guided resection to identify regions of increasing malignancy. Neuro Oncol. 2011 Aug; 13(8):846-56.

View in: PubMed
Franco RA, Dowdall JR, Bujold K, Amann C, Faquin W, Redmond RW, Kochevar IE. Photochemical repair of vocal fold microflap defects. Laryngoscope. 2011 Jun; 121(6):1244-51.

View in: PubMed
Kovacs KD, Quirk MT, Kinoshita T, Gautam S, Ceron OM, Murtha TJ, Arroyo JG. A retrospective analysis of triple combination therapy with intravitreal bevacizumab, posterior sub-tenon's triamcinolone acetonide, and low-fluence verteporfin photodynamic therapy in patients with neovascular age-related macular degeneration. Retina. 2011 Mar; 31(3):446-52.

View in: PubMed

People

Explore

Similar Concepts

Top Journals